1. Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21
   Boqian Zhu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
2. The Effect of lncRNA in Vascular Smooth Muscle Cells of Pulmonary Hypertension
   振航 凌, 2024, Hans Journal of Biomedicine CrossRef
3. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension
   Hua Su et al, 2018, RESPIRATORY RESEARCH CrossRef
4. Overexpressed long noncoding RNA CPS1‐IT alleviates pulmonary arterial hypertension in obstructive sleep apnea by reducing interleukin‐1β expression via HIF1 transcriptional activity
   Zeming Zhang et al, 2019, Journal of Cellular Physiology CrossRef
5. Analysis of lncRNA-miRNA-mRNA Interactions in Hyper-proliferative Human Pulmonary Arterial Smooth Muscle Cells
   Mahendran Chinnappan et al, 2019, Scientific Reports CrossRef
6. Early Evidence for the Role of lncRNA TUG1 in Vascular Remodelling in Pulmonary Hypertension
   Sébastien Bonnet et al, 2019, Canadian Journal of Cardiology CrossRef
7. Linking lncRNAs to regulation, pathogenesis, and diagnosis of pulmonary hypertension
   Yan Zhang et al, 2020, Critical Reviews in Clinical Laboratory Sciences CrossRef
8. LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1
   Lei Yang et al, 2019, Life Sciences CrossRef
9. Long non‐coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1‐AS1
   Katharina Jandl et al, 2019, The Journal of Pathology CrossRef